This inventor holds 40 USPTO granted patents and 15 published patent applications, plus 2 CIPO patents and 7 EPO patents, primarily in Organic Compounds. Top assignee: Intra-Cellular Therapies, Inc.. Active years: 2013-2026.
Company Filing History:
39 out of 181 Years Active: 2013-2026
Areas of Expertise:
Title: Innovations in Psychiatry: The Contributions of Sharon Mates
Introduction: Sharon Mates, based in New York, NY, is an influential inventor in the field of pharmaceuticals, holding an impressive 35 patents. His work primarily focuses on novel compositions and methods for treating mental health disorders, showcasing a commitment to advancing medical science.
Latest Patents: Among his latest innovations, Mates has developed pharmaceutical compositions comprising heterocycle fused gamma carboline prodrugs. This invention relates to specific prodrugs of substituted heterocycle fused gamma-carbolines, available in free, solid, pharmaceutically acceptable salts, and substantially pure forms. These compositions are designed for the treatment of diseases involving the 5-HT receptor, serotonin transporter (SERT), dopamine D and D2 receptor signaling systems, and the μ-opioid receptor. Additionally, Mates has disclosed methods for treating Bipolar II Disorder through the administration of a therapeutically effective amount of lumateperone, elaborated in either free or pharmaceutically acceptable salt form, potentially in a deuterated form.
Career Highlights: Throughout his career, Mates has been pivotal in the research and development of pharmaceutical innovations. His work not only results in substantial scientific advancements but also addresses pressing mental health issues impacting numerous patients worldwide.
Collaborations: Mates has collaborated with notable professionals in the field, including Lawrence P. Wennogle and Robert E. Davis. These partnerships have contributed to the evolution of his research, emphasizing the importance of collaborative efforts in driving innovation.
Conclusion: Sharon Mates exemplifies the impact of dedicated inventors in the pharmaceutical industry. His extensive portfolio of patents highlights his significant contributions to the treatment of mental health disorders. With ongoing research and development, Mates continues to pave the way for future innovations that could transform patient care and improve quality of life.